DIAGNOS Expands Agreement With Oftalmolaser de Mexico to Serve the Mexican Diabetes Association
(firmenpresse) - BROSSARD, QUEBEC -- (Marketwire) -- 09/11/12 -- DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in algorithm development, data analysis, and image processing, announces today the expansion of a diabetic retinopathy screening program with its Mexican representative Canamexport and partner OFTALMOLASER DE MEXICO S.A. DE C.V. (Oftalmolaser), the medical subsidiary of GRUPO DEVLYN, S.A. De C.V. (Devlyn) to serve the Mexican Diabetes Association (Asociacion Mexicana de Diabetes).
Under the terms of the expanded service agreement, DIAGNOS, and Oftalmolaser will offer DIAGNOS' Computer Assisted Retinal Analysis (CARA) technology in the Mexican Diabetes Association's clinics in Mexico. The service will include automated image processing (enhancement and analysis).
"We are very pleased with this expanded relationship in Mexico, and with Grupo Devlyn's continued leadership in providing ophthalmology services and their commitment to community service, including screening and blindness prevention. The joint commitment with the Mexican Diabetes Association to serve the Mexican diabetic population, will create a positive impact on the essential care of Mexican patients and will contribute to the decrease of the incidence of vision loss." said Peter Nowacki, DIAGNOS' Vice-President - Healthcare.
"We continue to deliver on our commitment as a family and as a business to the health of our communities, and plan to roll out CARA to support our screening for eye diseases at the Association's clinics to ultimately make a difference in the vision care of 15 million Mexicans with diabetes, 50% of whom are undiagnosed. This initiative is made possible by the leadership and foresight of the Association and we look forward to working with them and our partners DIAGNOS and Canamexport to make this a reality in the coming months." said Andrew Devlyn, Grupo Devlyn's Medical Division Director.
About Oftalmolaser
Oftalmolaser is a subsidiary of Grupo Devlyn and is a major provider of ophthalmic medical services, including surgical, services to its clients. Oftalmolaser currently operates 7 medical clinics in Mexico, and is growing its business throughout the region.
About Devlyn
Founded in 1963, Grupo Devlyn is private company that operates a retail chain of over 700 optical stores in Mexico, Central America and California, and is the largest optical chain in Latin America.
About DIAGNOS
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX VENTURE: ADK), with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision-making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare and natural resources.
For further information, please visit our website at or the SEDAR website at .
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.
Contacts:
Andre Larente, President
DIAGNOS Inc.
1-877-678-8882 or (450) 678-8882, ext. 224
Louis Morin
Bid Capital Markets
514-845-1101
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.09.2012 - 12:30 Uhr
Sprache: Deutsch
News-ID 182236
Anzahl Zeichen: 0
contact information:
Town:
BROSSARD, QUEBEC
Kategorie:
Software
Diese Pressemitteilung wurde bisher 128 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DIAGNOS Expands Agreement With Oftalmolaser de Mexico to Serve the Mexican Diabetes Association"
steht unter der journalistisch-redaktionellen Verantwortung von
Diagnos Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
